2023-02-01 12403147 2024-01-31 12403147 2023-02-01 2024-01-31 12403147 2023-01-31 12403147 2022-02-01 2023-01-31 12403147 uk-core:WithinOneYear 2023-01-31 12403147 uk-core:WithinOneYear 2024-01-31 12403147 uk-core:AfterOneYear 2023-01-31 12403147 uk-core:AfterOneYear 2024-01-31 12403147 uk-core:ShareCapital 2024-01-31 12403147 uk-core:ShareCapital 2023-01-31 12403147 uk-core:RetainedEarningsAccumulatedLosses 2024-01-31 12403147 uk-core:RetainedEarningsAccumulatedLosses 2023-01-31 12403147 uk-bus:Director1 2023-02-01 2024-01-31 12403147 uk-core:FurnitureFittings 2023-02-01 2024-01-31 12403147 uk-core:FurnitureFittings 2023-01-31 12403147 uk-core:Buildings 2023-01-31 12403147 uk-core:Buildings 2023-02-01 2024-01-31 12403147 uk-core:Buildings 2024-01-31 12403147 uk-core:FurnitureFittings 2024-01-31 iso4217:GBP xbrli:pure 12403147 uk-bus:AuditExemptWithAccountantsReport 2023-02-01 2024-01-31 12403147 uk-bus:FRS102 2023-02-01 2024-01-31 12403147 uk-bus:FilletedAccounts 2023-02-01 2024-01-31 12403147 uk-bus:EntityHasNeverTraded 2023-02-01 2024-01-31 12403147 uk-bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31
Route1 Pharma Limited
Registered Number:12403147
For the year ended 31 January 2024
England and Wales
Unaudited Financial Statements
2
For the year ended 31 January 2024
Route1 Pharma Limited
Contents Page
1
Statement of Financial Position
2 to 4
Notes to the Financial Statements
3
Registered Number :
12403147
As at 31 January 2024
Route1 Pharma Limited
Statement of Financial Position
£
£
2023
2024
Notes
Fixed assets
Property, plant and equipment
874,365
582,050
2
874,365
582,050
Current assets
Inventories
95,000
127,000
3
Trade and other receivables
13,991
43,316
4
155,607
Cash and cash equivalents
111,789
282,105
264,598
Trade and other payables: amounts falling due within one
year
(250,855)
(260,572)
5
13,743
21,533
Net current assets
Total assets less current liabilities
895,898
595,793
Trade and other payables: amounts falling due after more
than one year
(485,558)
(614,800)
6
281,098
Net assets
110,235
Capital and reserves
Called up share capital
2
2
Retained earnings
281,096
110,233
281,098
110,235
Shareholders' funds
For the year ended 31 January 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006
The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each
financial year and of its profit or loss for each financial year in accordance with the requirements of Section 394 and 395 and
which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as
applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Miss Puneeta Joshi Director
These financial statements were approved and authorised for issue by the Board on 12 March 2024 and were signed by:
The notes form part of these financial statements
1 of 4
4
For the year ended 31 January 2024
Route1 Pharma Limited
Notes to the Financial Statements
Statutory Information
Route1 Pharma Limited is a private limited company, limited by shares, domiciled in England and Wales, registration number
12403147.
Registered address:
46A Dukes Wood Avenue
Buckinghamshire
Gerrards Cross
England
SL9 7JU
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial Reporting Standard
102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The
financial statements have been prepared under the historical costs convention as modified by the revaluation of certain assets.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax or other similar sales taxes.
Property, plant and equipment
Property, plant and equipment, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery
15% Reducing balance
Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.
Inventories
Inventories are value at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme for the benefit of its directors/and employees. Contributions payable are charged to the profit and loss account in the period in which they are payable.
2 of 4
5
For the year ended 31 January 2024
Route1 Pharma Limited
Notes to the Financial Statements Continued
2. Property, plant and equipment
Total
Plant and
Machinery
Land and
Buildings
£
£
£
Cost or
valuation
At 01 February 2023
600,000
80,000
520,000
301,908
1,908
300,000
Additions
At 31 January 2024
820,000
81,908
901,908
Provision for depreciation and impairment
At 01 February 2023
17,950
17,950
-
Charge for year
9,593
9,593
-
At 31 January 2024
27,543
27,543
-
At 31 January 2024
Net book value
820,000
54,365
874,365
At 31 January 2023
520,000
62,050
582,050
3. Inventories
2023
2024
£
£
Stocks
127,000
95,000
4. Trade and other receivables
2023
2024
£
£
Other debtors
43,316
13,991
5. Trade and other payables: amounts falling due within one year
2023
2024
£
£
Taxation and social security
67,644
22,773
Other creditors
192,928
228,082
260,572
250,855
3 of 4
6
For the year ended 31 January 2024
Route1 Pharma Limited
Notes to the Financial Statements Continued
6. Trade and other payables: amounts falling due after more than one year
2023
2024
£
£
Other creditors
614,800
485,558
7. Average number of persons employed
During the year the average number of employees was 0 (2023 : 6)
4 of 4